Joe Loftus currently serves as the Head of the Alzheimer’s Disease Franchise at Biogen since November 2024 and is a Board Member at QuanBio.com. Prior experience includes a career at Novartis from July 2015 to November 2024, where responsibilities encompassed President and Head of Global Marketing for Novartis Gene Therapies, managing a $2 billion rare disease portfolio, and overseeing marketing strategies for a $3.4 billion multiple sclerosis portfolio. Additional roles at Novartis included Global Head of the Neurology Business Unit and US Head of Biopharmaceuticals, focusing on the commercialization of biosimilars. Prior to Novartis, Joe Loftus was Head of Global Marketing at Chemo and held the position of VP, Global Marketing at Mylan Pharmaceuticals. Joe Loftus earned a BS in Marketing and Economics from Penn State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices